as on March 2, 2026 at 9:31 pm IST
Day's Low
Day's High
1.56%
Downside
3.08%
Upside
52 Week's Low
52 Week's High
4.32%
Downside
85.46%
Upside
as on March 2, 2026 at 4:01 pm IST
Market Cap
₹373.16 Cr
Return on Equity (ROE)
4.93
PE Ratio (TTM)
48.44
Return on capital employed (ROCE)
8.21
Industry PE ratio
42.7
Beta (LTM)
0.75
P/B Ratio
1.61
Dividend Yield
0PEG Ratio
-28.33
Quarterly Earnings Growth YOY
10
EPS (TTM)
2.5
Sector
Pharmaceuticals
Book Value
51.49
Technical Analysis
Bearish
View Technical Analysis
as on March 2, 2026 at 4:01 pm IST
Zim Laboratories in the last 5 years
Lowest (6.12x)
June 11, 2018
Industry (42.70x)
February 27, 2026
Today (48.44x)
February 27, 2026
Highest (198.80x)
July 1, 2021
Today’s Price to Earnings Ratio: 48.44x
Compare market cap, revenue, PE, and other key metrics of Zim Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 373.16 | -3.59% | 0.66 | 12 | 379 | |
| NA | 86.32 | -7.95% | 0.71 | 10 | 120 | |
| NA | 99.48 | 5.38% | 0.00 | 3 | 75 | |
| BUY | 10,339.14 | -1.69% | 0.00 | 181 | 724 | |
| NA | 142.98 | 30.67% | 0.00 | 13 | 107 |
Search interest for Zim Laboratories Ltd Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Zim Laboratories.
Zim Laboratories Ltd’s net profit jumped 10% since last year same period to ₹4.40Cr in the Q3 2025-2026. On a quarterly growth basis, Zim Laboratories Ltd has generated 1147.62% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2019, Zim Laboratories Ltd has declared dividend of ₹0.50 per share on 22 May 2019 - translating a dividend yield of 2.15%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
![]()
Foreign Institutions have increased holdings from 0.00% to 0.02% in Dec 2025 quarter
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -1.87 Cr → 4.4 Cr (in ₹), with an average increase of 227.4% per quarter
Retail Holding Up
![]()
Retail Investor have increased holdings from 66.51% to 66.52% in Dec 2025 quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 73.23 Cr → 110.36 Cr (in ₹), with an average increase of 18.5% per quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 188.9% return, outperforming this stock by 203.5%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 46.4% return, outperforming this stock by 62.0%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 33.26% of holdings in Dec 2025 quarter
Price Dip
![]()
In the last 1 month, ZIMLAB stock has moved down by -6.4%
| Organisation | Zim Laboratories Ltd |
| Industry | Pharmaceuticals |
| CEO | Anwar S Daud |
| E-voting on shares | Click here to vote |
Zim Laboratories share price today stands at ₹68.48 as on at the close of the market. Zim Laboratories share today touched a day high of ₹70.59 and a low of ₹67.41.
Zim Laboratories touched a 52 week high of ₹127 and a 52 week low of ₹65.52. Zim Laboratories share price today i.e. is closed at ₹68.48, which is -46.08% down from its 52 week high and 4.52% up from its 52 week low.
Zim Laboratories market capitalisation is ₹373.16 Cr as on .
To buy Zim Laboratories shares, you need to follow these steps:
Zim Laboratories trading volume is 41.12K as on . This means that 41.12K shares of Zim Laboratories were bought and sold on the stock market during today's trading session.